Established in 2015, and founded by a team of highly experienced life science executives, agri-tech experts and serial entrepreneurs, Sade is focused on realizing the promise of medical cannabis and personalized healthcare.
initially established to research, manage and develop science-backed and evidence-based medicinal cannabis products, Sadé Biotech initiated several pre-clinical and clinical studies. These studies were seeking unique formulations and chemical compositions to treat specific medical symptoms. The result of three years of research was ASAYA™, a real-time digital healthcare platform built upon human and machine learning to power better care for patients.
Sade Biotech also is developing a smart, connected medical device –a unique mechanism that enables to administer a precise, consistent dose of medical cannabis oil along with improving its stability and quality. Using Bluetooth technology and interconnected to a smartphone, the device will help monitor treatment and provide precision on both chemovar as well as dosage.
Partnerships and investment in plant genetics mapping and analysis, and clinical research.
The company was founded as a leading scientific research company and initially worked in conjunction with the ARO, Israel’s governmental Agriculture Research Organization, but has since expanded its activities to include genetic and scientific research and the development of big data AI solutions.